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Genetic variation is the motor of evolution and allows organisms to overcome the envi-
ronmental challenges they encounter. It can be both beneficial and harmful in the process
of engineering cell factories for the production of proteins and chemicals. Throughout the
history of biotechnology, there have been efforts to exploit genetic variation in our favor to
create strains with favorable phenotypes. Genetic variation can either be present in nat-
ural populations or it can be artificially created by mutagenesis and selection or adaptive
laboratory evolution. On the other hand, unintended genetic variation during a long term pro-
duction process may lead to significant economic losses and it is important to understand
how to control this type of variation. With the emergence of next-generation sequencing
technologies, genetic variation in microbial strains can now be determined on an unprece-
dented scale and resolution by re-sequencing thousands of strains systematically. In this
article, we review challenges in the integration and analysis of large-scale re-sequencing
data, present an extensive overview of bioinformatics methods for predicting the effects of
genetic variants on protein function, and discuss approaches for interfacing existing bioin-
formatics approaches with genome-scale models of cellular processes in order to predict
effects of sequence variation on cellular phenotypes.
Keywords: genetic variation, SNP, next-generation sequencing, constraint-based modeling,metabolic engineering,
adaptive laboratory evolution, metabolism, high-throughput analysis
1. INTRODUCTION
Genetic engineering has been used for several decades to manip-
ulate microorganisms in order to allow production of valu-
able products, including primary metabolites (e.g., amino-acids
and organic acids), secondary metabolites (e.g., antibiotics), and
enzymes or other recombinant proteins (Adrio and Demain,
2010). Genetic engineering is thus a central part in the quest to
establish sustainable and efficient processes for the production of
fuels, chemicals, food ingredients, and pharmaceutical products.
Most of these achievements would not been possible without
sequencing technologies that allowed us to identify the genetic
sequences and validate the genetic manipulations in microorgan-
isms. More recently, Next-Generation Sequencing (NGS) tech-
nologies have provided us with the capability of fast and cheap
sequencing of DNA at an unprecedented scale. NGS has allowed
de novo assembly of the genomes of thousands of organisms for
which no genome sequences were previously available, ranging
from complex multicellular organisms (Li et al., 2010; Naka-
mura et al., 2013; Pegadaraju et al., 2013; Kelley et al., 2014)
to microorganisms (Soares-Castro and Santos, 2013; Yamamoto
et al., 2014). NGS technologies also provide us with the means to
re-sequence organisms (Atsumi et al., 2010; Wang et al., 2014), i.e.,
the sequencing of genetically distinct strains that are close enough
to a reference strain with a sequenced genome. Re-sequencing is
used to determine genetic variants ranging from single nucleotide
variants (SNV) to more complex structural variants such as
large deletions, inversions, and translocations. The falling cost of
sequencing allows routine re-sequencing of strains isolated from
the wild, monitoring the genetic stability of production strains
during genetic engineering and fermentation processes, and deter-
mining the genetic basis of adaptive laboratory evolution (ALE)
(Herrgård and Panagiotou, 2012). In addition to biotechnolog-
ical applications, re-sequencing of microbial strains plays also a
key role in other areas such as epidemiology of infectious diseases
caused by bacterial and fungal pathogens, and in understanding
the effects of human activity on microbial diversity and evolution
in the environment.
Genome-scale metabolic models (GSMs), consisting of bio-
chemical reactions and their relations to the genome and proteome
of a cell [through gene–protein-reaction (GPR) associations], are
a proven framework for the in silico analysis of the metabolic
physiology of microbes. Genome-scale metabolic models have also
been used successfully for the design of metabolically engineered
strains with improved production of commercially valuable pro-
teins and metabolites: recombinant antibodies, food additives
(e.g., vanillin), organic acids, ethanol, among others (Tepper and
Shlomi, 2009; Brochado et al., 2010). These models have become
increasingly popular over the past decade, and more than 100
models for different organisms have been published up to this
date (http://optflux.org/models). The greatest strength of GSMs
lie in their simplicity and computational efficiency; new GSMs
can be readily built from genomic annotations complemented
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with limited experimental data, and predictions from GSMs can
be obtained using standard mathematical optimization methods
(Varma and Palsson, 1993; Segrè et al., 2002; Shlomi et al., 2005)
allowing phenotypic predictions within minutes.
Genetic variation that entails a complete loss of function –
commonly referred to as gene knockout – has been successfully
used to tailor GSMs to a specific genotype to improve the produc-
tion of valuable compounds [e.g., biobutanol (Lee et al., 2008),
sesquiterpene (Asadollahi et al., 2009), vanillin (Brochado et al.,
2010), polyhydroxyalkanoates (Puchałka et al., 2008), or L-valine
(Park et al., 2007)], but so far no methodological framework has
been developed that would allow the incorporation of other types
of genetic variants systematically. In this work, we review exist-
ing tools for analyzing genetic variants that capture more subtle
changes such as synonymous and non-synonymous SNVs in cod-
ing regions or variants in promoter or other regulatory regions.
We will focus on outlining the challenges of combining more sub-
tle genetic variant information with GSMs in order to use models
to predict strain-specific phenotypes.
2. UNVEILING THE EFFECTS OF GENETIC VARIATION
2.1. GENETIC VARIABILITY
Genetic variants, including SNVs and larger structural variants
are commonly seen when natural or engineered strains are re-
sequenced (Figure 1). SNVs can be found across the genome
in different functional regions: (i) protein coding sequences, (ii)
promoters and other regulatory elements such as ribosome bind-
ing sites, (iii) splice sites and other regions affecting transcript
structures, and (iv) other genomic regions with unknown direct
connections to any given protein function. Moreover, insertions or
deletions of nucleotides (indels) within a coding region can cause a
shift in the open reading frame usually denoted as frameshift muta-
tions (Figure 1A). At the genome structure level, chromosomal
rearrangements, e.g., swaps, inversions, deletions, and insertions,
can affect the function of one or more proteins (Figure 1B).
The spectrum of the resulting effects caused by these genetic
variations on individual gene or protein function or expression
is very broad. Non-synonymous SNVs or in-frame indels in pro-
tein coding sequences can disrupt, enhance, or modify the activ-
ity of the protein depending on the exact amino-acid change
introduced. Introduction or removal of a stop codon by spe-
cific SNVs or out-of-frame indels would be expected to result
in more drastic changes of protein function. For example, the
appearance of a stop codon might lead to the separation of a
multi-domain protein to multiple individual single-domain pro-
teins. The removal or replacement of a stop codon could cause
translational read-through leading to an elongated protein with
potential new functions (Long et al., 2003). SNVs and indels in
regulatory regions such as promoters can affect the transcription
or translation processes giving rise to variation in expression levels
in specific proteins. In eukaryotes, variants within introns can also
affect transcript structures by introducing new exons or remov-
ing existing ones. Some variations can also be completely silent
with no change of phenotype, for example, a change in a stop
codon location might not change the protein activity. Ideally, we
should be able to predict the degree in which single and multiple
genetic variants within or near a coding locus affect the relevant
protein function or expression. This would allow us to rapidly
make sense of the vast quantities of re-sequencing data that is
becoming available without having to test the effects of all variants
experimentally.
Larger-scale structural variations, such as duplications, dele-
tions, translocations, and inversions, can have significant effects
on the expression or activity of individual proteins. For example,
there can be a complete loss of one or more genes, or a dupli-
cation of genomic regions can modify the expression of multiple
genes within or nearby these regions (Blount et al., 2012). Very
large-scale genomic changes, such as duplication of entire chro-
mosomes, can change the activity of hundreds of proteins at once
and have been reported in both natural microbial strains (Gordon
et al., 2009) and in strains created by ALE (Caspeta et al., 2014).
The effects of structural genomic variation are often more systemic
than the effects of smaller scale variations, but any framework
attempting to predict the phenotypic effects of genetic variation
needs to consider both small- and large-scale variation.
2.2. IN SILICO : PREDICTING THE EFFECT OF GENETIC VARIANTS
A major challenge to understanding the phenotypic consequences
of genetic variation lies in our ability to predict the mechanistic
consequences of mutations. Proteins are very complex structures
FIGURE 1 | Common genetic variations. Variations at the (A) nucleotide level and (B) structural level. (C) Single nucleotide polymorphism A/T across a
population.
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that fall into different functional categories and can be charac-
terized by many distinct properties. For example, how protein
activities are measured depends on their functional category: tran-
scription factors can be characterized by their binding strength to
a certain promoter region while metabolic enzymes would typi-
cally be characterized by their catalytic activity and specificity for
a certain substrate. Moreover, proteins do not operate in isolation
but interact with each other and with metabolites, and these inter-
actions have consequences on the activities of proteins. Here, we
provide a non-exhaustive review of the types of methods that are
commonly used to predict the effects of genetic variants on protein
function.
The study of single nucleotide polymorphisms (SNP) that affect
human health is one of the major focus areas of modern medical
research. In human genetics, SNPs are single nucleotide substitu-
tions found in more than 1% of a population. Several algorithms
were implemented to determine the effect of SNPs, mostly spe-
cialized to the analysis of human genotyping data (see Table 1 and
Figure 2). One limitation of most of these algorithms is that they
are binary classifiers – deleterious or neutral, disease-causing or
neutral, and tolerant or intolerant. This means that the genetic
changes will either be predicted to have no effect or to cause
some measurable, negative impact on the phenotype. This may
not be an issue in the context of human diseases as SNP data are
primarily used in diagnostics. However, fine tuning engineered
microbial strains requires more than a black and white approach
for predicting variant effects on protein function. This is because
many genetic variants can yield proteins with either increased or
decreased activity, requiring methods that are able to predict also
potential gains or modifications of functions. In particular, when
mutagenesis and selection or ALE methods are applied, one com-
monly sees gain of function mutations of specific genes that are
crucial for the adaptation to, for example, new carbon sources
(Conrad et al., 2011).
Of the existing algorithms (Table 1), SIFT (Sorting Intolerant
f rom Tolerant) (Ng and Henikoff, 2001) is often used as a gold
standard to compare the performance of new algorithms or as
a foundation for novel prediction strategies. SIFT and related
approaches are based on the notion that evolutionary conservation
can be used to predict the functional importance of each amino-
acid in a protein and the impact of specific amino-acid substitu-
tions. These methods typically use multiple sequence alignments
of related proteins to determine a probabilistic description of what
amino-acid substitutions are allowed in specific sites within the
target protein. These descriptions can be used to determine the
probability that non-synonymous coding SNPs observed in a re-
sequencing data set will be tolerated by the protein; substitutions
with a probability score smaller than a threshold are assumed to
be deleterious (Kumar et al., 2009).
Sorting intolerant from tolerant provides only a binary
deleterious/non-deleterious classification, and other methods
have been developed to allow predicting cases where SNPs improve
protein function. The Polyphen (Ramensky, 2002) and PolyPhen2
(Adzhubei et al., 2010) approaches provide the means to discrim-
inate three states when analyzing the effect of a SNP: benign,
neutral, or deleterious. Polyphen uses a list of predetermined
rules that combine the output of multiple algorithms using
combinations of structural and sequence-based measures of muta-
tion impact. PolyPhen2 uses a machine-learning approach (a naive
Bayes model) to predict an overall score for the variant effect,
and the classification to three categories is based on thresholds.
Although the algorithm is trained with human datasets, similar
methods could potentially be used to build predictive models for
variant effects in microorganisms. The overall variant effect score
could also be exploited in more advanced methods that combine
scores from different variants affecting different proteins to make
phenotypic predictions.
Most studies on genetic variation focus on SNPs and disregard
indels, which are also commonly observed when related microbial
strains are compared to each other. The PROVEAN (Choi et al.,
2012) and Mutation taster 2 (Schwarz et al., 2014) approaches are
capable of analyzing both SNPs and indels. PROVEAN uses sub-
stitution matrix scores (i.e., BLOSUM62) with gap and extension
penalties to compute a variation score between the wild-type and
mutant. More recently,Mutation taster 2 computes several features
(structural and evolutionary properties) for the mutated sequence
using a Bayes classifier.
One possible approach for improving our ability to predict
variant effects on protein function would be to predict effects of
amino-acid changes on protein stability and folding (Khan and
Vihinen, 2010). There are a number of tools available for these
tasks (Khan and Vihinen, 2010), and stability predictions could
be used to predict variant effects on protein function, as strongly
destabilizing mutations would result in complete loss of function
for the protein. Methods for predicting variant effects on protein
stability have only been found to be moderately accurate in inde-
pendent evaluation studies (Khan and Vihinen, 2010). For this
reason, stability predictors should be combined with other vari-
ant effect prediction approaches to improve their predictive power
for general variant effect analysis. The application of these types
of stability prediction methods will be discussed in Section 3.2 in
more detail together with the applications of metabolic modeling.
The majority of algorithms (53%) for variant effect predic-
tion listed in Table 1 rely on machine-learning approaches [e.g.,
AUTO-MUTE (Masso and Vaisman, 2010), FunSAV (Wang et al.,
2012), or HANSA (Acharya and Nagarajaram, 2011)], which is
a practical strategy given the huge amount of data available for
human diseases. Regarding the selection of features, most meth-
ods use evolutionary conservation information (92%) and more
than half rely on structural properties (69%). The selection of suf-
ficient features is a challenge in itself; no matter what approach
is used, it is necessary to define which properties and attributes
of proteins are capable of discriminating the phenotypes of inter-
est. The improvements in the prediction capabilities provided by
sequence-, evolution-, or structural-based features has been pre-
viously studied, and these studies have shown that the inclusion
of structural properties leads to significant improvements in pre-
dictive power (Saunders and Baker, 2002). This has been recently
confirmed by a benchmark performance test that includes several
of the existing algorithms (Thusberg et al., 2011). Another effort
to benchmark and improve different approaches is the Critical
Assessment of Genome Interpretation (CAGI) community, which
organizes a benchmark competition on predicting the effect of
genetic variants on known disease phenotypes.
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Table 1 | A summary of the available software tools for predicting the effect of the genetic variants.
Tool Description Reference
AUTO-MUTE Uses the “4-Body Statistical Potential” to compute a set of features – based on protein 3D
structure – used to train a Random Forest model to predict neutral or disease-associated SNPs.
Masso and Vaisman (2010)
Align-GVGD This algorithm is based on multiple sequence alignment and Grantham distance to identify missense
SNPs. The authors propose a measure to calculate how much the substitution changes the Grantham
distance.
Tavtigian (2005)
CADD A machine-learning approach that uses a SVM model to predict deleterious phenotypes caused by
SNPs.
Kircher et al. (2014)
Chasman and
Adams (2001)
A probabilistic approach to identify which SNPs have an effect on the protein function using structural
and evolutionary features that compare the variation against a dataset of mutations of lac repressor
and T4 lysozyme.
Chasman and Adams
(2001)
CONDEL Consensus deleteriousness provides a score computed based on the weighted average of the
normalized scores of five different tools: LogR.E-value, MAPP, mutation assessor, polyphen, and STIF.
González-Pérez and
López-Bigas (2011)
Evolutionary
action
Evolutionary action is a function that links genotype with phenotype using evolutionary information,
by quantifying the impact of SNPs on the fitness of a population; it correlates with
disease-associated mutations.
Katsonis and Lichtarge
(2014)
FATHMM Uses Hidden Markov Models (HMMs) to obtain position-specific information. The prediction is based
on the probability change of the HMM between wild-type and mutant.
Shihab et al. (2012)
FunSAV A random forest classifier for predicting deleterious SNPs. It combines properties of the mutated
protein with other tools (i.e., nsSNPAnalyzer, PANTHER, PhD-SNP, PolyPhen2, SIFT, and SNAP).
Wang et al. (2012)
FuzzySnps A machine-learning approach that uses a Random Forest model trained by combining “4-Body
Statistical Potential” and sequence-based features to identify tolerant and intolerant SNPs.
Barenboim et al. (2008)
Goldgar et al.
(2004)
A probabilistic approach to determine if a SNP is disease-causing, which is achieved by computing
the likelihood of the protein to be similar to previously classified mutated proteins in a dataset.
Goldgar et al. (2004)
HANSA It is a machine-learning classifier that uses a SVM model to predict whether a SNP will be neutral or
disease-causing.
Acharya and Nagarajaram
(2011)
LogR.E-value Uses the E -value computed by the HMMER algorithm using PFAM motifs to distinguish between
deleterious and neutral SNPs.
Clifford et al. (2004)
LS-SNP A workflow/database that uses predefined rules and machine-learning (SVN) approach to
systematically characterize known SNPs.
Karchin et al. (2005)
Krishnan and
Westhead (2003)
Two machine-learning approaches – using SVM and Decision Trees models – are used to predict the
“effect” or “no-effect” of a SNP.
Krishnan and Westhead
(2003)
MAPP MultivariateAnalysis of Protein Polymorphism uses statistical analysis to predict the deleterious
effect of SNPs.
Stone (2005)
Mutation
assessor
Predicts the degree of impact in a protein by scoring the mutation based on the impact it causes
regarding the properties of a multiple sequence alignment of homologous sequences.
Reva et al. (2011)
Mutation taster 2 Uses a Bayes classifier to predict disease associated effects caused by SNPs or Indels. The classifier
uses a set of features that includes splicing site and polyadenylation signal information along with
structural and evolutionary properties.
Schwarz et al. (2014)
MutPred Uses a machine-learning approach to predict disease or neutral SNPs. The features used refer to a
probability of loss or gain of function regarding several functional and structural properties of the
encoded protein. The authors trained SVM and Random Forest models in this work.
Li et al. (2009)
nsSNPAnalyzer Uses a Random Forest model trained with features (consisting of SIFT score and information from
multiple sequence alignment and protein 3D structures) to identify disease associated SNPs.
Bao et al. (2005)
Papepro A SVM prediction model is used by the authors to separate deleterious from neutral SNPs. Tian et al. (2007)
(Continued)
Frontiers in Bioengineering and Biotechnology | Systems Biology February 2015 | Volume 3 | Article 13 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cardoso et al. Genetic variation and metabolic modeling
Table 1 | Continued
Tool Description Reference
Panther Using an internal database of HMM, an evolutionary score is computed and the method predicts
deleterious or neutral effects with a probability attached. The cutoff can be defined by the user
(default is 3).
Thomas and Kejariwal
(2004)
PhD-SNP This approach uses one of two SVM models: one is trained using sequence profile features and the
other is trained using sequence features. The choice of which model to use is based on a preliminary
decision: if the mutation exists in the homology profile, the first model is used, otherwise the
prediction is done using the second model.
Capriotti et al. (2006)
PMut Predicts pathological or neutral effects of amino-acid substitutions. The prediction model is a neural
network using structural-, physicochemical-, and evolutionary-based features, all calculated using
sequence information only (without requiring a3D protein structure).
Ferrer-Costa et al. (2005)
Polyphen A set of rules defined by the authors is used to predict the effect of a SNP. These rules are built based
on three properties: PSIC score, substitution site properties, and substitution type properties. If one
of the rules matches, the output can be deleterious or benign, otherwise the substitution is classified
as neutral.
Ramensky (2002)
PolyPhen2 The follow up version of Polyphen, uses a naive Bayes predictor to predict damaging, benign, or
neutral effects of SNPs. It uses structural information if available.
Adzhubei et al. (2010)
PROVEAN ProteinVariation EffectANalyzer computes a score based on evolutionary information to predict if a
genetic variant (i.e., SNP or Indel) is neutral or deleterious.
Choi et al. (2012)
RCOL Applies a Bayes’ formula to calculate the probability of a SNP to be deleterious. The likelihood is
tested using 20 structural and physicochemical parameters.
Terp et al. (2002)
SAPRED Using a SVM prediction model, the authors combine features computed from evolutionary, structural,
and physicochemical properties to predict disease associated SNPs.
Ye et al. (2007)
SIFT Using a PSSM, SIFT determines the probability of a substitution being tolerated in a given position. Ng and Henikoff (2001)
SNAP Identifies non-neutral SNPs using machine-learning approaches that combines a battery of Neural
Network models.
Bromberg et al. (2008)
SNPs3D Combines a set of features obtained from protein 3D structure and evolutionary information to
predict deleterious effects using a SVM model.
Yue et al. (2006)
SNPs&GO A machine-learning approach that includes GO annotations as features in a SVM model to predict
whether a SNP is neutral or disease associated.
Calabrese et al. (2009)
SNPs&GO3D It is the successor of SNPs&GO. It includes new features obtained from protein 3D structure. Capriotti and Altman (2011)
Sunyaev (2001) This approach uses a set of seven rules empirically defined by the authors to identify nsSNPs. If one
of the rules is matched, then the SNP is likely to be deleterious.
Sunyaev (2001)
SuSPect A SVM model implementation to predict disease phenotypes caused by SNPs. The authors started
with a high number of features until they identified nine that provided best performance.
Yates et al. (2014)
VarMode A machine-learning approach using a SVN model to predict the effect of SNPs that includes
information regarding known protein–protein interactions. It predicts non-synonymous SNPs.
Pappalardo and Wass
(2014)
While the majority of algorithms aim to predict variant effects
on individual proteins, a different objective is followed by the SNP-
IN method that predicts how protein–protein interactions (PPIs)
are affected by a SNP (Zhao et al., 2014). This is achieved by a set of
features that includes the relative free energy change between wild-
type and mutant PPI, the energy of all interactions in a protein
complex, and other physicochemical properties, e.g., hydrophobic
solvation or water bridges. Using these features, supervised and
semi-supervised machine-learning approaches are used to predict
how deleterious SNPs are. This approach is a very interesting, as
changes in PPIs could be used to explain epistatic interactions
between multiple variants. Like some previously mentioned pre-
diction algorithms, SNP-PI requires an existing 3D model of the
protein structure and, in addition, knowledge of the PPIs a given
protein is involved in.
At a larger scale, genome-wide association studies are used
to identify how differences between hundreds of thousands of
individuals and make genotype to phenotype consequences. This
approaches work as black boxes and make use of statistical and
machine-learning approaches that require huge datasets. The
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FIGURE 2 | Summary of properties and approaches for software listed in
Table 1. The approaches found fall into four different categories: Machine-
Learning, Probabilistic, Score (calculating a summarizing score of a set of
hand-picked statistics), and Rule (using a set of empirically derived rules).
These approaches provide one of two types of classifications each: a binary
classification (e.g., neutral or deleterious) or a multi-classification (e.g.,
benign, neutral, and deleterious). The features used by those approaches
can be computed based on properties of the following five categories:
(i) physicochemical properties (e.g., solvent accessibility, polarity, charge,
disorder, and Grantham), (ii) structural information about the primary,
secondary, and tertiary structure of a protein (e.g., α-helices, β-sheets, and
coil), (iii) evolutionary properties (multiple sequence alignments,
position-specific scoring matrices, and Hidden Markov models), and
(iv) genome annotation (GO terms or other protein function annotations). The
supported variants were determined either by accessing the tools’ websites
or by the description of the approach itself.
current work and applications (e.g., clinical risk assessment) have
been recently reviewed (Okser et al., 2014).
2.3. IN VIVO : DEEP MUTATIONAL SCANNING AND TN-SEQ
Next-generation sequencing has enabled studying the effects of
genetic variation on individual proteins or regulatory elements
in vivo and in vitro. Deep mutational scanning (DMS) is an
effective high-throughput method to measure the effects of muta-
tions on protein stability and function (Fowler and Fields, 2014).
The space of all possible amino-acid substitutions in a protein is
exhaustively screened by first constructing a library of sequence
variants using standard techniques like error prone PCR, then by
using a high-throughput assay to select variants based on a fitness
measure (e.g., growth rate, ligand binding, or product fluores-
cence), and finally by applying deep sequencing to the selected
and unselected sequence variant pools. This approach results in
a matrix that contains fitness values for each amino-acid substi-
tution discovered in the selected pool. Depending on the method
used for creating sequence diversity and sequencing depth, DMS
can also be used to measure epistatic effects between substitutions
at different sites.
The applicability of DMS is primarily limited by the lack of
high-throughput functional assays for most proteins and, so far,
DMS has not been applied to metabolic enzymes. When DMS
can be applied at a broader scale, the results obtained from the
assay could increase the predictive power of bioinformatic tools
for genetic variation analysis by providing more complete train-
ing datasets for the types of predictive methods discussed in the
previous section. Methods similar to DMS can also be used to sys-
tematically study effects of genetic variation in regulatory regions
on protein expression using fluorescence protein-based assays.
Here, we will highlight a few case studies using DMS and
related methods to study protein or regulatory element function.
In the analysis of Saccharomyces cerevisiae poly(A)-binding protein
(Melamed et al., 2013), strong epistatic effects between substi-
tutions at specific sites were discovered. Although epistasis was
not widespread, this is worrying from a computational model-
ing perspective, as modeling approaches usually do not account
for epistasis. Another important highlight is the identification of
alternative start codons. Although analyzed in previous studies,
the DMS has shown that some amino-acids can be replaced by
methionine and yield functional proteins (Kim et al., 2013). This
biological information can be extrapolated to other studies and is
highly relevant when developing strategies to understand the effect
of mutations, either in vivo or in silico. Strategies similar to DMS
have also been used to systematically study the effects of variation
in transcription factor binding sites and other regulatory elements
such as ribosomal binding sites (Kosuri et al., 2013). These stud-
ies will build the foundation for predicting effects of non-coding
sequence variants on protein expression.
The methods described above allow us to systematically study
the effects of a large number of variants in individual pro-
teins or regulatory regions. In microorganisms, it is also possible
to use a next-generation sequencing-based method called Tn-
seq to systematically study the effect of disruption of a large
number of genomic loci on cellular phenotypes (van Opijnen
and Camilli, 2013). Transposons are mobile DNA elements that
can disrupt a genetic locus by integrating themselves into it
(Figure 1B). Tn-seq, using high density transposon insertion
libraries, can be used to interrogate the function of, for exam-
ple, regulatory elements and specific protein domains in a single
genome-wide assay (van Opijnen and Camilli, 2013). Tn-seq has
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found many applications in microbiology, and it has been used
for the identification of gene function, understanding genome
organization, mapping genetic interactions, or assessing gene
essentiality (van Opijnen and Camilli, 2013; Yang et al., 2014).
Tn-seq does not offer a resolution on the single base-pair level,
but the method can be rapidly used to generate sub-gene-level
information relating, for example, to the essentiality of specific
domains in a protein. This information in turn could be used
to improve variant effect predictions, as variants in essential
domains of a protein would be more likely to be predicted to
be deleterious than variants in non-essential domains of the same
protein.
3. PREDICTING PHENOTYPES FROM GENOTYPES AT THE
GENOME-SCALE
3.1. STATISTICAL AND NETWORK-ORIENTED APPROACHES FOR
PREDICTING PHENOTYPES FROM GENOTYPES
Section 2 focused on the task of predicting the effects of genetic
variation on individual protein function or expression. However,
this is only a small part of a much larger problem, which of pre-
dicting cellular or organism phenotypic effects of all the genetic
variants present in a genome. This requires combing the effects
of variation on the function and expression of all proteins. So far,
there have been surprisingly few efforts to take all genetic variants
discovered in an individual (either a human or a microbial strain)
and attempt to predict how certain phenotypes would be affected
by all these variants together (Burga and Lehner, 2013; Lehner,
2013).
One of the first systematic attempts toward this goal was the
pioneering study by Jelier et al. in S. cerevisiae, where growth phe-
notypes of selected yeast strains under different conditions were
predicted from genetic differences between a reference strain and
the strain of interest (Jelier et al., 2011). This was achieved by
first predicting effects of coding and regulatory variants on pro-
tein function and expression using approaches similar to the one
outlined in the previous section. These variant effect predictions
were then combined into a single phenotypic prediction for the
strain, using published single gene deletion growth phenotyping
data for a yeast reference strain under the same condition. This
approach can be considered to be highly simplistic, as the effects of
multiple genetic variants acting on separate proteins were treated
cumulative. Despite this, the approach still allowed accurate pre-
diction of growth phenotypes across a broad range of conditions.
There have also been a number of other approaches for predicting
broader phenotypic consequences of single variants by mapping
the variant data onto biological networks such as PPI or genetic
networks (Carter et al., 2013). However, these approaches have
typically not attempted to use the whole genotype of an indi-
vidual (i.e., more than one variant at a time) to predict specific
phenotypes.
3.2. USING GENOME-SCALE METABOLIC MODELS FOR INTERPRETING
GENETIC VARIANTS
The phenotype prediction methods described above are
data-driven and use statistical models to predict the effects of
genetic variants in the context of biological networks. However,
for metabolic networks we can go beyond statistical models and
graph-based descriptions to constraint-based models that are scal-
able to the genome-level and incorporate physicochemical, flux
capacity, and reaction directionality constraints [see Price et al.
(2004) for a review of constraint-based modeling]. This type of
mechanistic modeling approach is very useful for understand-
ing genetic changes that affect specific metabolic phenotypes. For
example, the study of SNPs that affect mitochondrial metabolism
(Jamshidi and Palsson, 2006) is a good example of how variant
data can be mapped onto metabolic networks in order to explain
the mechanistic basis of disease phenotypes.
A genome-scale metabolic models are composed of biochemi-
cal reactions, collected from literature and the genome annotation
of an organism. This system of reactions is encoded as a matrix
of stoichiometric coefficients that is usually referred to as stoi-
chiometry matrix1. Assuming metabolism is in a steady-state, i.e.,
metabolite concentrations do not change over time, all fluxes have
to balance each other. These flux-balances constitute linear con-
straints that can easily be analyzed using methods from linear
algebra.
Furthermore, after inclusion of further constraints, e.g., known
uptake and secretion rates and knowledge about reaction direc-
tionality, linear optimization methods can compute biologically
relevant flux vectors that maximize defined objective functions.
For example, growth can be simulated by maximizing the con-
sumption of biomass precursors in empirically determined pro-
portions. This type of analysis is usually referred to as flux bal-
ance analysis [FBA; see Orth et al. (2010) for a comprehensive
introduction to this method].
Global optimal solutions to this linear optimization problems
can be calculated very efficiently using linear programing (compu-
tation times are on a millisecond to second range for genome-scale
models). Thus, one can compute thousands of phenotypes in
a few minutes, simply by changing the constraints of the prob-
lem [see Lewis et al. (2012) for a comprehensive list of available
in silico methods and (Bordbar et al., 2014) for a review of their
applications].
Since the relationship between reactions, enzymes, and genes
(usually referred to as GPR associations) is usually known and
encoded in these models, the effect of a gene knockout can readily
be mapped to the associated reactions by constraining their fluxes
to be zero or by removal from the model. This way FBA can be
used to compute the metabolic phenotype associated with a meta-
bolic gene deletion, making it suitable for the analysis of genetic
variation data that involves deletions or other mutations that lead
to the complete loss of function of enzymes.
Flux balance analysis assumes that knockout strains can recover
to an optimal growth phenotype, which might be unrealistic in
cases where regulatory mechanisms – not modeled explicitly in
these models – might not be able to accommodate the desired
state. Other methodologies [e.g., ROOM (Shlomi et al., 2005),
MoMA (Segrè et al., 2002), MiMBl (Brochado et al., 2012), and
RELATCH (Kim and Reed, 2012)] employ more plausible assump-
tions and have been shown to improve the accuracy of knockout
1The rows and columns of the stoichiometry matrix correspond to metabo-
lites and reactions respectively; negative (positive) factors represent consumption
(production) of substrates (products).
www.frontiersin.org February 2015 | Volume 3 | Article 13 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cardoso et al. Genetic variation and metabolic modeling
predictions. For example, MoMA minimizes the euclidean dis-
tance of the wild-type and mutant flux distributions, assuming
that a mutant reaches the closest feasible flux distribution that is
not necessarily optimal. The predictive power of FBA and these
other approaches have been extensively assessed using genome-
wide gene knockout assays (Snitkin et al., 2008) and transposon
insertion libraries (Yang et al., 2014) and have resulted generally
in a high degree of accuracy (Monk and Palsson, 2014).
Constraint-based models have also been applied to predict
epistatic interactions by simulating effects of pairwise gene dele-
tions, but with a significantly reduced accuracy in comparison to
single deletions (Szappanos et al., 2011). Furthermore, simulations
of multiple gene deletions have been successfully applied in devel-
oping design strategies for metabolic engineering by redirecting
flux to desired products (Milne et al., 2009; Blazeck and Alper,
2010).
A number of limiting factors can diminish the ability of
constraint-based models to predict phenotypic effects of loss of
function mutations: (i) missing reactions and erroneous GPRs,
(ii) erroneous flux constraints due to the lack of thermodynamic
or regulatory information, and (iii) the assumption of a fixed
biomass composition that is known to change across growth con-
ditions. Even with these limitations, constraint-based models still
outperform statistical models in predicting consequences of gene
deletions (Szappanos et al., 2011).
Since constraint-based models have demonstrated good ability
to predict phenotypic outcomes of single and multiple gene dele-
tions, these models should also be useful for predicting effects of
other genetic variants. A SNV or indel that is predicted to reduce
the maximal flux rate of an enzyme can be used to constrain the
upper bound of a flux. FBA and similar methods can be used to
compute the effects of these variations on the phenotype, provid-
ing a system-wide overview of the effects caused by the substitution
(Jamshidi et al., 2007). This is a fast and effective way of predict-
ing phenotypes, but it requires that one can estimate the effect
the variant has on the maximum flux rate. Nevertheless, cases of
complete loss of function fall into the same category as gene knock-
outs, and combining the bioinformatic prediction tools discussed
in Section 2.2 with modeling capabilities can be used to integrate
variant data. This approach can also be extended to any number
of variants and genes, with the caveat that epistatic interactions
are currently not captured accurately by the models.
There is currently only a limited number of studies that use
GSMs to systematically explore the effects of genetic variants on
phenotypes. Chang et al. (2013) conducted a study where GSMs
coupled with protein structures of metabolic enzymes (GEM-
PRO2) were used to interpret genetic variant data of Escherichia
coli strains evolved to tolerate high temperatures (Chang et al.,
2013). In this study, a GSM of E. coli was constrained using
experimentally or bioinformatically determined thermostabilities
of metabolic enzymes. Since the maximum flux capacity of a
reaction is proportional to the concentration of active enzyme,
temperature changes can be modeled by varying the flux con-
straints accordingly. This enables the prediction of enzymatic steps
2Genome-scale metabolic models are sometimes also referred to as GEMs.
that are disproportionately temperature sensitive. For the evolved
strains, flux balance analysis was used to explore the adaptation
of the mutated enzymes; constraints associated with mutated pro-
teins were relaxed to explain the experimentally measured growth
rates (Chang et al., 2013). The study did not include separate pre-
dictions of variant effects on protein function, but rather treated
all variants observed in a protein as potentially affecting its activity.
A more recent study by Nam et al. (2014) describes the use
of GSMs for understanding the metabolic effects of cancer muta-
tions. In particular, Nam et al. use genetic mutation information,
gene expression profile data, and a human GSM (Thiele et al.,
2013) to construct context-specific models for different cancer
types. Loss and gain of function were systematically analyzed. Loss
of function was modeled as described above (i.e., constraining
affected reactions’ fluxes to 0). Gain of a function, on the other
hand, was modeled by adding novel promiscuous activities as pre-
dicted by chemoinformatic approaches. This approach allowed the
prediction of potential oncometabolites.
3.3. KINETIC MODELING OF GENETIC VARIANTS
As mentioned in the previous section, constraint-based modeling
does not provide any information about the dynamic behavior
of a metabolic system. A full kinetic description of a biochemi-
cal reaction network can be formulated using ordinary differential
equations (Heinrich and Schuster, 1996). The major advantage of
using kinetic models to study effects of genetic variation lies in
their ability to account for mutations affecting catalytic or regu-
latory sites of an enzyme, causing either a gain or loss of catalytic
activity, or binding sites of allosteric regulators.
Previous studies of red blood cell metabolism provide an
overview on how SNPs can alter kinetic parameters and how
kinetic models can be used to explain metabolic syndromes caused
by enzyme deficiencies (Jamshidi, 2002; Jamshidi and Palsson,
2009). A disadvantage of using kinetic models is that kinetic para-
meters are not available for most enzymes and measuring the
parameters can be challenging. For this reason, building predictive
genome-scale kinetic models remains a challenge (Stanford et al.,
2013). Kinetic models are a viable tool for interpreting genetic
variant data only in specific cases like, for example, the red blood
cell that harbors a relatively simple metabolism.
4. CONSIDERATIONS AND FUTURE DIRECTIONS
4.1. METHODS AND TOOLS TO PREDICT THE EFFECT OF GENETIC
VARIANTS
Many approaches have been explored in the past decade to under-
stand and analyze the effects of genetic variation. In particular,
the most active field has been the application of NGS techniques
to characterize of genetic variation in the context of human dis-
ease. The amount of disease related information makes machine-
learning approaches very suitable for the purpose of predicting
effects of single genetic variants. Since most prediction methods
have been trained and tested with human data, many of the exist-
ing methods do not perform as well or are simply not suited for
the analysis of microbial genetic variants.
The other area where the study of microbial genetic variation
lags behind human genetics is the systematic collection of vari-
ant and phenotyping data. Efforts to collect human genotype and
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phenotype data in a standardized way are currently underway
with databases such as dbSNP and European Variation Archive.
The UniProt database also collects variants found in the proteins
sequences when this information is available. Every day thousands
of new environmental or pathogenic isolates and laboratory devel-
oped microbial strains are sequenced around the world, but there
is no centralized repository for this data in common use. We argue
that it is of utmost importance to collect genetic variant data
together with associated phenotypic data in a standard way for
microbes as well.
All the existing algorithms for variant effect prediction are used
to classify variants to preassigned categories (for example deleteri-
ous or non-deleterious). The approaches that predict deleterious
effects can already be handled as knockouts in modeling their phe-
notypic effects using GSMs, but more subtle effects of mutations
are missed by this approach. In order to improve our ability to
predict phenotypes, there is a need to move beyond classifica-
tion toward quantitative measures of variant effects on individual
protein function. There are numerous features related to protein
function that may be relevant for predicting variant effects: evolu-
tionary and conservation, physicochemical (e.g., charge, polarity,
or free energy), and structural (e.g., secondary structures, spatial
distances between amino-acids or B-factors).
Existing methods for predicting variant effects have been pri-
marily focused on generic predictors for all proteins irrespective of
their function (e.g., enzymes, transcription factors, transporters,
chaperons, etc.) and how do they behave in their environment
(i.e., interaction with other elements: proteins, metabolites, DNA,
etc.). This limits the predictive power of the methods in cases
where additional information is readily available such as the rel-
atively well studied field of microbial metabolism. For example,
for metabolic enzymes, information on how kinetic parameters
are affected by mutations and how these parameters vary between
enzymes from different species is systematically collected in data-
bases such as BRENDA. This type of information could be used to
build improved variant effect predictors specifically for metabolic
enzymes.
4.2. MODELING AND HIGH-THROUGHPUT DATA ANALYSIS
Improvements in genome-wide variant effect prediction can
also come from improving or extending genome-scale modeling
approaches. Recent innovations like GEM-PRO, as discussed in
Section 3.2, fulfill the requirement of 3D protein structures to pre-
dict the effects of genetic variation at the protein level and could
be used to systematically analyze the effect of genetic variation on
a genome-scale for metabolism.
Approximately 10–30% of the genes encoded in a microbial
genome are represented in metabolic GSMs, limiting the utility
of these models for interpreting genomic variant data. Metabolic
GSMs can be extended in a number of ways to increase cov-
erage of the overall set of genes. The transcriptional regulatory
network represented as interactions between transcription factors
and target genes, can help extend the coverage of predictive mod-
els and can be integrated with metabolic GSMs in a number of
ways (Covert et al., 2004; Chandrasekaran and Price, 2010). These
integrated models have been successfully used to make phenotypic
predictions.
Another recent extension of GSMs is ME-Models3. These mod-
els account for the entire machinery needed for gene and protein
expression, providing a higher coverage of cellular functions and
a higher resolution of cellular composition (O’Brien et al., 2013).
ME-models have also been extended further to incorporate pro-
tein translocation from the cytoplasm to the periplasm (Liu et al.,
2014). Currently, most of these extensions of GSMs have only been
developed forE. coli and significant efforts will be required to build
these extended models for other bacteria as well as eukaryotic
model organisms such as S. cerevisiae.
The development of accurate kinetic models of metabolism,
which could be useful for investigating the effects of mutations on
allosteric regulation and catalytic activity, is still a tedious process.
These models are usually limited to small parts of metabolism
focusing on central carbon metabolism (Chassagnole et al., 2002;
Peskov et al., 2012; Machado et al., 2014). There are two main
reasons for these limitations: the models become huge in size and
kinetic information of many enzymes is still unknown. Protocols
(Stanford et al., 2013) and methodologies (Chowdhury et al., 2014)
are being developed to bring kinetic modeling to the genome-scale,
but the resulting models have not yet reached sufficiently mature
stage for use in variant effect prediction.
In comprehensive level, a strategy for building whole-cell mod-
els by combining multiple individual models of different cellu-
lar processes including cell cycle, metabolism, transcription, and
transport has been proposed (Karr et al., 2012). This strategy
that also allows combining models using different representa-
tions (constraint-based, kinetic, and stochastic) was used to build a
functioning whole-cell model of one of the simplest prokaryotes,
Mycoplasma genitalium. Efforts toward building more complete
genome-scale models of microbes will continue as more and more
information is collected and computing power increases. These
models will bring us closer to the goal of genome-wide prediction
of phenotypes from genotyping data.
4.3. OPPORTUNITIES
Genetic engineering tools, such as MAGE (Wang et al., 2009) or
CRISPR/Cas9 (Xu et al., 2014), already allow us to quickly edit
genomes in a precise and accurate fashion at the single base-pair
resolution level at multiple loci simultaneously. These methods
will allow us to map epistatic interactions of variants within a sin-
gle gene and between multiple genes more comprehensively than
before. On the other hand, new in silico tools for predicting variant
effects on phenotypes outlined above open the way to a new style
of modeling at the scale of single nucleotides. These new model-
ing tools will greatly benefit from better training datasets that can
be obtained using MAGE, CRISPR/Cas9 or other genome editing
methods systematically to map epistatic interactions. The applica-
tion of these novel strategies provides a way to fine tune activities
of proteins in the context of complete cellular networks. For exam-
ple, we envision that in the future we will have predictive models
of how engineering of multiple enzymes at the single amino-acid
level would affect the production of a desired metabolite.
To achieve the maximum potential of genome-scale biochem-
ical network modeling and genetic variant analysis, a link must
3Metabolism and Expression models.
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be created between these two fields. The necessary information to
connect both worlds is already there: we know the genes, the pro-
teins, and the reactions. The major limitations are in the current
methods and data sources. On the one hand, we must overcome
the limitations of the tools available to predict variant effects by
allowing more fine grained predictions of how a variant may affect
any given protein function or expression. The usage of protein
folding predictions, for example, has already been established in
metabolic modeling (Chang et al., 2013), and it should be possible
to use tools that predict variant effects on protein stability together
with genome-scale models. On the other hand, we need to improve
biochemical network modeling techniques: this is a evolving field
and in the past decade there have been efforts to standardize the
construction of models (Thiele and Palsson, 2010) and improving
prediction methods by including high-throughput data (Machado
and Herrgård, 2014).
Finally, it should be acknowledged that there will always be
limitations in using solely genomic variant data as the basis for
making phenotypic predictions for specific strains. We may also
need to measure intermediate phenotypes such as transcript, pro-
tein, or metabolite levels for these strains in order to make pre-
dictions of how a given genotype affects a specific phenotype
(Burga and Lehner, 2013). Fortunately enough comprehensive
multi-omic datasets are currently being collected for wild-type
microbial strains, allowing refinement of modeling and bioinfor-
matic approaches for phenotypic prediction (Ishii et al., 2007;
Skelly et al., 2013). Hopefully, systematizing such datasets and a
concerted action between modelers, geneticists, microbiologists,
and bioinformaticians will allow us to achieve the prediction of
changed and novel metabolic capabilities of a microbial strain
from genomic re-sequencing data.
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